Holger Reithinger - Profile and Investment Details

Investor Profile

Holger Reithinger is a Venture Capital, Investor based in Munich, Bavaria, Germany with a diverse investment portfolio that includes companies such as Santaris Pharma, AM Pharma, 3i Deutschland GmbH, Pathway Medical Technologies, Impella Cardiosystems, Borean Pharma, Cellnovo Group SA, Roche Glycart, NovoGI, Munich Biotech AG, Oxyrane UKAgendia, OMEICOS Therapeutics, Inflazome, Fibrex Medical Inc., Amakem, Pulmologix, Seamless Therapeutics, Ardana Bioscience, CoviCept Therapeutics, Rigontec, FlowMedica, Oxular, NeRRe Therapeutics, Hookipa Pharma, NorthSea Therapeutics, SANIFIT, PneumRx, Gotham Therapeutics, Catalym, Insmed, Mitralign, Prilenia, KaNDy Therapeutics, Ario Pharma, Cardoz, CircuLite, BioVex, Curetis AG, Cytheris, Bluebird Bio, CatalYm GmbH, Pieris AG, UniQure, CellNovo, Akarna Therapeutics, Escalier Biosciences, Azafaros, Enterprise Therapeutics, Bioceros, Rigontec GmbH, Replimune Group, Exosome Diagnostics, Acorda Therapeutics, Dyne Therapeutics, gIcare Pharma, Amphista Therapeutics, 4SC AG, OMEICOS Therapeutics GmbH, Curetis Group, Milestone Pharmaceuticals, Dezima Pharma, Fovea Pharmaceuticals, Inversago Pharma, Gyroscope Therapeutics, New Amsterdam Pharma, Autonomic Technologies, Xention, Achilles Therapeutics, Forbion, arGEN-X, Curetis, ACADIA Pharmaceuticals, Allecra Therapeutics, PanGenetics, Promedior, Transave, Argos Therapeutics, enGene, Prexton Therapeutics, . Over time, Holger Reithinger has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Holger Reithinger is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Mobility, Genetics, Wellness, Enterprise Software, Life Science, Engineering, Biotechnology, Medical Devices, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Innovation, Research, Consumer Software, Agriculture, Technology Transfer, Health Diagnostics, Digital Health, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Pharmaceuticals may find it worthwhile to explore potential connections with Holger Reithinger, as their portfolio suggests a familiarity and interest in this area.

Understanding Holger Reithinger’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.